Ortin Laboratories Limited
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-p… Read more
Market Cap & Net Worth: Ortin Laboratories Limited (ORTINLAB)
Ortin Laboratories Limited (NSE:ORTINLAB) has a market capitalization of $1.84 Million (₹159.62 Million) as of March 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #35582 globally and #1981 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ortin Laboratories Limited's stock price ₹19.63 by its total outstanding shares 8131390 (8.13 Million).
Ortin Laboratories Limited Market Cap History: 2015 to 2024
Ortin Laboratories Limited's market capitalization history from 2015 to 2024. Data shows change from $3.30 Million to $1.84 Million (-0.63% CAGR).
Ortin Laboratories Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ortin Laboratories Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.09x
Ortin Laboratories Limited's market cap is 0.09 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.30 Million | $392.43 Million | $8.98 Million | 0.01x | 0.37x |
| 2016 | $2.07 Million | $397.69 Million | $8.34 Million | 0.01x | 0.25x |
| 2017 | $3.15 Million | $422.86 Million | $3.93 Million | 0.01x | 0.80x |
| 2018 | $1.61 Million | $797.03 Million | $6.79 Million | 0.00x | 0.24x |
| 2019 | $1.02 Million | $1.63 Billion | $12.80 Million | 0.00x | 0.08x |
| 2020 | $3.04 Million | $1.96 Billion | -$5.64 Million | 0.00x | N/A |
| 2021 | $3.13 Million | $81.67 Million | $9.45 Million | 0.04x | 0.33x |
| 2022 | $2.23 Million | $82.31 Million | -$3.99 Million | 0.03x | N/A |
| 2023 | $2.17 Million | $60.20 Million | -$669.00K | 0.04x | N/A |
| 2024 | $1.84 Million | $21.11 Million | -$80.41 Million | 0.09x | N/A |
Competitor Companies of ORTINLAB by Market Capitalization
Companies near Ortin Laboratories Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Ortin Laboratories Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Ortin Laboratories Limited Historical Marketcap From 2015 to 2024
Between 2015 and today, Ortin Laboratories Limited's market cap moved from $3.30 Million to $ 1.84 Million, with a yearly change of -0.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | ₹1.84 Million | -15.02% |
| 2023 | ₹2.17 Million | -2.74% |
| 2022 | ₹2.23 Million | -28.68% |
| 2021 | ₹3.13 Million | +2.78% |
| 2020 | ₹3.04 Million | +197.52% |
| 2019 | ₹1.02 Million | -36.54% |
| 2018 | ₹1.61 Million | -48.85% |
| 2017 | ₹3.15 Million | +52.50% |
| 2016 | ₹2.07 Million | -37.50% |
| 2015 | ₹3.30 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2025 the market cap of Ortin Laboratories Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.84 Million USD |
| MoneyControl | $1.84 Million USD |
| MarketWatch | $1.84 Million USD |
| marketcap.company | $1.84 Million USD |
| Reuters | $1.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.